UK Pharma Exports To Fall 22% In No-Deal Brexit

Third Countries Would Benefit From Europe’s Loss

 
• By Ian Schofield
Decreasing_Graph
A no-deal Brexit would see a decline in UK and EU pharma competitiveness • Source: Shutterstock

More from Manufacturing

More from Compliance